Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19

References

• COVID-ICU Group for the R Network and the C-I Investigators. Clinical characteristics and day-90 outcomes of 4,244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2020:1–14. DOI:https://doi.org/10.1007/s00134-020-06294-x.
   Google Scholar
• Richards-Belle A, Orzechowska I, Gould DW, et al. COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2020;46(11):2035–2047.
   PubMed Web of Science ®Google Scholar
• Vena A, Giacobbe DR, Di Biagio A, et al. Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clin Microbiol Infect. 2020;26(11):1537–1544.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Battaglini D, Robba C, Ball L, et al. Emerging therapies for COVID-19 pneumonia. Expert Opin Investig Drugs. 2020;29(7):633–637.
   PubMed Web of Science ®Google Scholar
• Robba C, Battaglini D, Pelosi P, et al. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 14(9): 865–868. 2020.
   PubMed Web of Science ®Google Scholar
• Robba C, Battaglini D, Ball L, et al. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir Physiol Neurobiol. 2020;279:103455.
   PubMed Web of Science ®Google Scholar
• Pelosi P, D’Onofrio D, Chiumello D, et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J. 2003;22(Supplement 42):48s–56s.
   Web of Science ®Google Scholar
• Dorward DA, Russell CD, Um IH, et al. Tissue-specific immmunopathology in fatal COVID-19. Am J Respir Crit Care Med. 2021;203(2):192–201.
   PubMed Web of Science ®Google Scholar
• Patel BV, Arachchillage DJ, Ridge CA, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202(5):690–699.
   PubMed Web of Science ®Google Scholar
• Elinoff JM, Salit RB, Ackerman HC. The tumor lysis syndrome. N Engl J Med. 2011;365:571–572.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Camporota L, Marini JJ. COVID-19 phenotypes: leading or misleading? Eur Respir J. 2020;56(2):2002195.
   PubMed Web of Science ®Google Scholar
• Chiumello D, Busana M, Coppola S, et al. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med. 2020;46(12):2187–2196.
   PubMed Web of Science ®Google Scholar
• Herrmann J, Mori V, Bates JHT, et al. Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia. Nat Commun. 2020;11(1):4883.
   PubMed Web of Science ®Google Scholar
• Goligher EC, Jonkman AH, Dianti J, et al. Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort. Intensive Care Med. 2020;46(12):2314–2326.
   PubMed Web of Science ®Google Scholar
• Dhont S, Derom E, Van Braeckel E, et al. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res. 21(1): 198. 2020.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
   PubMed Web of Science ®Google Scholar
• Zucman N, Mullaert J, Roux D, et al. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med. 2020;46(10):1924–1926.
   PubMed Web of Science ®Google Scholar
• Sivaloganathan AA, Nasim-Mohi M, Brown MM, et al. Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre. Br J Anaesth. 2020;125(4):e368–e371.
   PubMed Web of Science ®Google Scholar
• Franco C, Facciolongo N, Tonelli R, et al. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia. Eur Respir J. 2020;56(5):2002130.
   PubMed Web of Science ®Google Scholar
• Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438–442.
   PubMed Web of Science ®Google Scholar
• Xia J, Zhang Y, Ni L, et al. High-flow nasal oxygen in coronavirus disease 2019 patients with acute hypoxemic respiratory failure: a multicenter, retrospective cohort study. Crit Care Med. 2020;48(11):e1079–e1086.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhao W, Li J, et al. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care. 2020;10(1):37.
   PubMed Web of Science ®Google Scholar
• Duan J, Chen B, Liu X, et al. Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19: a multicenter observational study. Am J Emerg Med. 2020. DOI:https://doi.org/10.1016/j.ajem.2020.07.071.
   Google Scholar
• Agarwal A, Basmaji J, Muttalib F, et al. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020;67(9):1217–1248.
   PubMed Web of Science ®Google Scholar
• Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020;55(5):2000892.
   PubMed Web of Science ®Google Scholar
• Battaglini D, Robba C, Caiffa S, et al. Chest physiotherapy: an important adjuvant in critically ill mechanically ventilated patients with COVID-19. Respir Physiol Neurobiol. 2020;282:103529.
   PubMed Web of Science ®Google Scholar
• Bellani G, Grasselli G, Cecconi M, et al. Noninvasive ventilatory support of COVID-19 patients outside the intensive care units (WARd-COVID). Ann Am Thorac Soc. 2021. DOI:https://doi.org/10.1513/AnnalsATS.202008-1080OC.
   Google Scholar
• Aliberti S, Radovanovic D, Billi F, et al. Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J. 2020;56(4):2001935.
   PubMed Web of Science ®Google Scholar
• Fan E, Del Sorbo L, Goligher EC, et al. An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253–1263.
   PubMed Web of Science ®Google Scholar
• Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020;48(6):e440–e469.
   PubMed Web of Science ®Google Scholar
• Menk M, Estenssoro E, Sahetya SK, et al. Current and evolving standards of care for patients with ARDS. Intensive Care Med. 2020;46(12):2157–2167.
   PubMed Web of Science ®Google Scholar
• Perchiazzi G, Pellegrini M, Chiodaroli E, et al. The use of positive end expiratory pressure in patients affected by COVID-19: time to reconsider the relation between morphology and physiology. Best Pract Res Clin Anaesthesiol. 2020;34(3):561–567.
   PubMed Web of Science ®Google Scholar
• Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854–887.
   PubMed Web of Science ®Google Scholar
• Guérin C, Reignier J, Richard J-C, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168.
   PubMed Web of Science ®Google Scholar
• Gleissman H, Forsgren A, Andersson E, et al. Prone positioning in mechanically ventilated patients with severe acute respiratory distress syndrome and coronavirus disease 2019. Acta Anaesthesiol Scand. 2020;65(3):aas.13741.
   PubMed Web of Science ®Google Scholar
• Mittermaier M, Pickerodt P, Kurth F, et al. Evaluation of PEEP and prone positioning in early COVID-19 ARDS. EClinicalMedicine. 2020;28:100579.
   PubMedGoogle Scholar
• Pelosi P, Brazzi L, Gattinoni L. Prone position in acute respiratory distress syndrome. Eur Respir J. 2002;20(4):1017–1028.
   PubMed Web of Science ®Google Scholar
• Ferrando C, Mellado-Artigas R, Gea A, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study. Crit Care. 24(1): 597. 2020.
   PubMed Web of Science ®Google Scholar
• Bower G, He H. Protocol for awake prone positioning in COVID-19 patients: to do it earlier, easier, and longer. Crit Care. 2020;24(1):371.
   PubMed Web of Science ®Google Scholar
• Caputo ND, Strayer RJ, Levitan R. Early self-proning in awake, non-intubated patients in the emergency department: a single ED’s experience during the COVID-19 pandemic. Acad Emerg Med. 2020;27(5):375–378.
   PubMed Web of Science ®Google Scholar
• Carlos F, Ricard MA, Alfredo G, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study. Crit Care. 2020;24(1):597.
   PubMed Web of Science ®Google Scholar
• Koeckerling D, Barker J, Mudalige NL, et al. Awake prone positioning in COVID-19. Thorax. 2020;75(10):833–834.
   PubMed Web of Science ®Google Scholar
• Bagate F, Tuffet S, Masi P, et al. Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome. Ann Intensive Care. 2020;10(1):151.
   PubMed Web of Science ®Google Scholar
• Longobardo A, Montanari C, Shulman R, et al. Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome. Br J Anaesth. 2020;S0007–0912:30843–30846.
   Google Scholar
• Tavazzi G, Marco P, Mongodi S, et al. Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia. Crit Care. 2020;24(1):508.
   PubMed Web of Science ®Google Scholar
• Wiegand SB, Safaee Fakhr B, Carroll RW, et al. Rescue treatment with high-dose gaseous nitric oxide in spontaneously breathing patients with severe coronavirus disease 2019. Crit Care Explor. 2020;2(11):e0277.
   PubMedGoogle Scholar
• Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–1363.
   PubMed Web of Science ®Google Scholar
• Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA. 2018;320(21):2251.
   PubMed Web of Science ®Google Scholar
• ELSO. COVID-19 registry dashboard [Internet]; 2020. Available from: https://www.elso.org/Registry/FullCOVID19RegistryDashboard.aspx
   Google Scholar
• Cho HJ, Heinsar S, Jeong IS, et al. ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review. Crit Care. 2020;24(1):301.
   PubMed Web of Science ®Google Scholar
• Combes A, Fanelli V, Pham T, et al. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. 2019;45(5):592–600.
   PubMed Web of Science ®Google Scholar
• Amato MBP, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747–755.
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Juffermans NP, Matthay MA, et al. From protective ventilation to super-protective ventilation for acute respiratory distress syndrome. Intensive Care Med. 2013;39(5):963–965.
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629.
   PubMed Web of Science ®Google Scholar
• Sieswerda E, De Boer MGJ, Bonten MMJ, et al. Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline. Clin Microbiol Infect. 2020;27(1):61–66.
   PubMed Web of Science ®Google Scholar
• Ding Q, Lu P, Fan Y, et al. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020;92(9):1549–1555.
   PubMed Web of Science ®Google Scholar
• Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–1379.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
   PubMed Web of Science ®Google Scholar
• Bell BG, Schellevis F, Stobberingh E, et al. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14(1):13.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61–e111.
   PubMed Web of Science ®Google Scholar
• Mason CY, Kanitkar T, Richardson CJ, et al. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics. J Antimicrob Chemother. 2021;dkaa563. DOI:https://doi.org/10.1093/jac/dkaa563.
   Google Scholar
• Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia. JAMA. 2020;323(9):885.
   PubMed Web of Science ®Google Scholar
• Tanzella G, Motos A, Battaglini D, et al. Optimal approaches to preventing severe community-acquired pneumonia. Expert Rev Respir Med. 2019;13(10):1005–1018.
   PubMed Web of Science ®Google Scholar
• Rello J, Belliato M, Dimopoulos M-A, et al. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens international symposium. Anaesth Crit Care Pain Med. 2020;39(6):723–730.
   PubMed Web of Science ®Google Scholar
• Dellière S, Dudoignon E, Fodil S, et al. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2020. DOI:https://doi.org/10.1016/j.cmi.2020.12.005.
   Google Scholar
• Reyes L, Sanchez-Garcia MA, Morrison T, et al. Proteomics identifies a type I IFN, prothrombotic hyperinflammatory circulating COVID-19 neutrophil signature distinct from non-COVID-19 ARDS. medRxiv. 2020. DOI:https://doi.org/10.1101/2020.09.15.20195305.
   Google Scholar
• Klok FA, Kruip MJHA, Van Der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Carsana L, Sonzogni A, Ahmed Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135–1140.
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 18(5): 1094–1099. 2020.
   PubMed Web of Science ®Google Scholar
• Atallah B, Mallah SI, AlMahmeed W. Anticoagulation in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):260–261.
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19. J Thromb Haemost. 2020;18(8):1859–1865.
   PubMed Web of Science ®Google Scholar
• Zhai Z, Li C, Chen Y, et al. Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost. 2020;120(6):937–948.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1–11.
   Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Shang L, Zhao J, Hu Y, et al. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395(10225):683–684.
   PubMed Web of Science ®Google Scholar
• Qu TT, Yang Q, Yu MH, et al. A fatal Strongyloides stercoralis hyperinfection syndrome in a patient with chronic kidney disease: a case report and literature review. Medicine (Baltimore). 2016;95(19):e3638.
   PubMed Web of Science ®Google Scholar
• Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–475.
   PubMed Web of Science ®Google Scholar
• Yang J-W, Yang L, Luo R-G, et al. Corticosteroid administration for viral pneumonia: COVID-19 and beyond. Clin Microbiol Infect. 2020;26(9):1171–1177.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu H, Wang W, et al. Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies. Expert Rev Anticancer Ther. 2020;21(1):107–119.
   PubMed Web of Science ®Google Scholar
• Horby P, Shen Lim W, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N Engl J Med. 2020.
   Web of Science ®Google Scholar
• Angus DC, Derde L, Al-Beidh F, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19. JAMA. 2020;324(13):1317.
   PubMed Web of Science ®Google Scholar
• Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19. JAMA. 2020;324(13):1307.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19. JAMA. 2020;324(13):1330.
   PubMed Web of Science ®Google Scholar
• De Backer D, Azoulay E, Vincent J-L. Corticosteroids in severe COVID-19: a critical view of the evidence. Crit Care. 2020;24(1):627.
   PubMed Web of Science ®Google Scholar
• Angus DC, Derde L, Al-Beidh F, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020 Oct 6;324(13):1317–1329.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569–1578.
   PubMed Web of Science ®Google Scholar
• Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 383(19): 1827–1837. 2020.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou F, Zhang D, et al. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020;21(1):422.
   PubMed Web of Science ®Google Scholar
• WHO. COVID-19 treatment guidelines [Internet]. NIH; 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/
   Google Scholar
• Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787–1799.
   PubMed Web of Science ®Google Scholar
• Maxmen A. More than 80 clinical trials launch to test coronavirus treatments. Nature. 2020;578(7795):347–348.
   PubMed Web of Science ®Google Scholar
• Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732–739.
   PubMed Web of Science ®Google Scholar
• FDA. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems; 2020 [cited 2020 Jul 1]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or
   Google Scholar
• Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382(25):2411–2418.
   PubMed Web of Science ®Google Scholar
• Ortiz-Alcantara J, Bhardwaj K, Palaninathan S, et al. Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease. Virus Adapt Treat. 2010;2:125.
   Google Scholar
• Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci. 2020;117(17):9490–9496.
   PubMed Web of Science ®Google Scholar
• Chai KL, Valk SJ, Piechotta V, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020;10:CD013600.
   PubMedGoogle Scholar
• Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19. JAMA. 324(5): 460. 2020.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Dolci G, Massari M, et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia. JAMA Intern Med. 2020:; 181(1): 24-31.
   Google Scholar
• Mitchell V, Dravid R, Patel A, et al. Difficult airway society guidelines for the management of tracheal extubation. Anaesthesia. 2012;67(3):318–340.
   PubMed Web of Science ®Google Scholar
• Ovadya D, Bachar K, Peled M, et al. Weaning of severe COVID-19 mechanically ventilated patients: experience within a dedicated unit in Israel. Isr Med Assoc J. 2020;22(12):733–735.
   PubMed Web of Science ®Google Scholar
• Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a position paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020;90(1). DOI:https://doi.org/10.4081/monaldi.2020.1285
   Web of Science ®Google Scholar
• Kangas-Dick AW, Swearingen B, Wan E, et al. Safe extubation during the COVID-19 pandemic. Respir Med. 2020;170:106038.
   PubMed Web of Science ®Google Scholar
• D’Silva DF, McCulloch TJ, Lim JS, et al. Extubation of patients with COVID-19. Br J Anaesth. 2020;125(1):e192–e195.
   PubMed Web of Science ®Google Scholar
• Botti C, Lusetti F, Peroni S, et al. The role of tracheotomy and timing of weaning and decannulation in patients affected by severe COVID-19. Ear Nose Throat J. 2020;100(2_suppl):116S-119S.
   Web of Science ®Google Scholar
• Avilés-Jurado FX, Prieto-Alhambra D, González-Sánchez N, et al. Timing, complications, and safety of tracheotomy in critically ill patients with COVID-19. JAMA Otolaryngol Neck Surg. 2020;147(1):1-8.
   PubMed Web of Science ®Google Scholar
• McGrath BA, Brenner MJ, Warrillow SJ, et al. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance. Lancet Respir Med. 2020;8(7):717–725.
   PubMed Web of Science ®Google Scholar
• Quah P, Li A, Phua J. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care. 2020;24(1):285.
   PubMed Web of Science ®Google Scholar